Search
Search Results
##search.searchResults.foundPlural##
-
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2475PDF: 1040HTML: 11179 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
435PDF: 429HTML: 235 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3994PDF: 1774HTML: 11962Figures Haase: 295 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2311PDF: 1092HTML: 4115Cover Letter: 283Figure 1: 285Figure 2: 274Table 1: 260 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2856PDF: 1108HTML: 2403 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2031PDF: 1250HTML: 352 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3546PDF: 1624HTML: 4092 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1335PDF: 636HTML: 286 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1857PDF: 2092Suppl. Files: 290HTML: 123 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1310PDF: 654HTML: 6941 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3047PDF: 1053HTML: 7523 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1786PDF: 885HTML: 973cover letter: 366 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1480PDF: 931HTML: 5099INSTITUTE PUBLICATION COMMITTEE APPROVAL: 215 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3950PDF: 1326HTML: 5103Incidence age-standardized rates for HL across the Mediterranean basin: 259 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1885PDF: 604HTML: 325 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277916PDF: 1906HTML: 3912 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4979PDF: 1637HTML: 2284Untitled: 278Untitled: 298Untitled: 315Untitled: 268Untitled: 283 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2348PDF: 1067HTML: 1994 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2265PDF: 911HTML: 1658Figure 1: 603 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2761PDF: 1355HTML: 3630Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 461 -
-
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1798PDF: 1169HTML: 199 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2103PDF: 868HTML: 642 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3433PDF: 1115HTML: 2596 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1916PDF: 1266HTML: 364







